Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q73245623)
Watch
English
Psoriasis
scientific article published on 01 April 2003
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12686053
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12686053%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
review article
1 reference
stated in
Europe PubMed Central
title
Psoriasis
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12686053
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12686053%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
author name string
Mark Lebwohl
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12686053
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12686053%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
language of work or name
English
0 references
publication date
1 April 2003
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12686053
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12686053%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12686053
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12686053%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
volume
361
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12686053
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12686053%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
issue
9364
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12686053
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12686053%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
page(s)
1197-1204
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12686053
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12686053%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
cites work
Infectious complications of erythrodermic psoriasis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Psoriatic arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Psoriatic arthritis in psoriatic patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Psoriasis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Psoriasis in practice.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The pathophysiology of psoriasis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Psoriasis in Australian twins.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genetic aspects of psoriasis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Searching for the major histocompatibility complex psoriasis susceptibility gene.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Coding haplotype analysis supports HCR as the putative susceptibility gene for psoriasis at the MHC PSORS1 locus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Corneodesmosin expression in psoriasis vulgaris differs from normal skin and other inflammatory skin disorders
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Characterization of Mononuclear Cell Infiltrates in Psoriatic Lesions
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: further evidence for adoptive autoimmunity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The immunologic basis for the treatment of psoriasis with new biologic agents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Biologic therapy for psoriasis: the new therapeutic frontier
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Out-patient treatment of psoriasis: short contact and overnight dithranol therapy compared
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vitamin D analogs: mechanism of action and therapeutic applications
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Psoriasis remission time at the Dead Sea.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of gastrointestinal symptoms associated with methotrexate therapy for psoriasis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Methotrexate in psoriasis: consensus conference
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acitretin in combination with UVB or PUVA.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pimecrolimus identifies a common genomic anti-inflammatory profile, is clinically highly effective in psoriasis and is well tolerated
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A multicenter dose-escalation trial with denileukin diftitox (ONTAK, DAB(389)IL-2) in patients with severe psoriasis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Successful in vivo blockade of CD25 (high-affinity interleukin 2 receptor) on T cells by administration of humanized anti-Tac antibody to patients with psoriasis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunomodulation by interleukin-10 therapy decreases the incidence of relapse and prolongs the relapse-free interval in Psoriasis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Etretinate or cyclosporin-A treatment normalizes the enhanced respiratory burst of polymorphonuclear leukocytes in psoriasis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Narrowband UV-B phototherapy vs photochemotherapy in the treatment of chronic plaque-type psoriasis: a paired comparison study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Calcitriol 3 microg g-1 ointment in combination with ultraviolet B phototherapy for the treatment of plaque psoriasis: results of a comparative study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment with anti-tumor necrosis factor alpha (TNF-alpha) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Review article: the risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anti-TNF therapy and malignancy - a critical review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of psoriatic arthritis with antitumour necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFalpha antibody
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Infliximab (anti-tumor necrosis factor alpha antibody): a novel, highly effective treatment of recalcitrant subcorneal pustular dermatosis (Sneddon-Wilkinson disease)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
RETRACTED: Infliximab in patients with primary Sjögren's syndrome: a pilot study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Remission of Behçet's syndrome with tumour necrosis factor alpha blocking therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of longstanding active giant cell arteritis with infliximab: report of four cases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Infliximab for refractory ulcerative colitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A cost-cost study comparing etanercept with infliximab in rheumatoid arthritis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Drug-induced systemic lupus erythematosus associated with etanercept therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Etanercept-induced subacute cutaneous lupus erythematosus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence for a possible association with infections
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of recalcitrant cicatricial pemphigoid with the tumor necrosis factor alpha antagonist etanercept
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Successful treatment of Langerhans'-cell histiocytosis with etanercept
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Rapid remission of treatment-resistant ankylosing spondylitis with etanercept--a drug for refractory ankylosing spondylitis?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Psoriasis as a model for T-cell-mediated disease: immunobiologic and clinical effects of treatment with multiple doses of efalizumab, an anti-CD11a antibody.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anti-E-selectin is ineffective in the treatment of psoriasis: a randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Administration of DAB389IL-2 to patients with recalcitrant psoriasis: a double-blind, phase II multicenter trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912954-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(03)12954-6
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12686053
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12686053%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
PubMed publication ID
12686053
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12686053
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12686053%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit